NCT02826837 2021-10-06
LEAC-102 for Advanced Colorectal Cancer
Taiwan Leader Biotech Corp.
Phase 1/2 Unknown
Clinical Trials
4 trialsNCT05035914 2021-09-05
Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer
Guangzhou University of Traditional Chinese Medicine
Phase 1/2 Unknown
NCT04929652 2021-06-18
Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 1/2 Unknown
NCT04337879 2020-07-21
A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown